Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2015
Single Nucleotide Polymorphisms as Genomic Markers for High-Throughput Pharmacogenomic StudiesAnnalisa Lonetti, Maria Chiara Fontana, Giovanni Martinelli, et al.International Journal of Molecular Sciences|June 6, 2019
Acute Myeloid Leukemia Mutations: Therapeutic ImplicationsCristina Papayannidis, Chiara Sartor, Giovanni Marconi, et al.BMC Cancer|November 17, 2018
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemiaLuca Bertamini, Jacopo Nanni, Giovanni Marconi, et al.Biomedicines|April 30, 2021
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3aMaria Chiara Fontana, Jacopo Nanni, Andrea Ghelli Luserna di Rorà, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2022
Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T CellsGiulia Corradi, Barbara Bassani, Giorgia Simonetti, et al.Cell Biology and Toxicology|September 14, 2021
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cellsAndrea Ghelli Luserna Di Rorà, Martina Ghetti, Lorenzo Ledda, et al.Journal of Oncology|December 13, 2019
Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid LeukemiaSamantha Bruno, Maria Teresa Bochicchio, Eugenia Franchini, et al.Leukemia Research|January 1, 2021
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patientsGiovanni Marconi, Stefano De Polo, Giovanni Martinelli, et al.European Journal of Haematology|March 8, 2020
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemiaGiovanni Marconi, Annalisa Talami, Maria Chiara Abbenante, et al.Journal of Hematology & Oncology|August 3, 2018
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemiaAndrea Ghelli Luserna Di Rorà, Neil Beeharry, Enrica Imbrogno, et al.Pageof 2